Presentation is loading. Please wait.

Presentation is loading. Please wait.

Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program.

Similar presentations


Presentation on theme: "Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program."— Presentation transcript:

1 Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program population-based study  Atanu Bhattacharjee, Tapesh Bhattacharyya, Abin Thomas  Clinical Epidemiology and Global Health  Volume 6, Issue 2, Pages (June 2018) DOI: /j.cegh Copyright © Terms and Conditions

2 Fig. 1 Comparison of different types of metastasis and death occurrence in HER2 Positive, HER2Negative, and HER2 Borderline. Clinical Epidemiology and Global Health 2018 6, 88-93DOI: ( /j.cegh ) Copyright © Terms and Conditions

3 Fig 2 Comparison of Overall Survival(OS)betweenHER2 Positive, HER2Negative and HER2 Borderline. Clinical Epidemiology and Global Health 2018 6, 88-93DOI: ( /j.cegh ) Copyright © Terms and Conditions

4 Fig. 3 Forest Plot with Cox PH Model Performance in HER2 Positive, HER2Negative, and HER2 Borderline. Clinical Epidemiology and Global Health 2018 6, 88-93DOI: ( /j.cegh ) Copyright © Terms and Conditions


Download ppt "Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program."

Similar presentations


Ads by Google